Tora-Dol 30 mg/ml soluzione iniettabile clinical trials

Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST CARE Trial)

This study looks at new ways to help people having major cancer surgery. It's testing if certain medicines can reduce serious problems like infections or other issues that can happen after big operations, especially for those who might be more likely to have inflammation.